Topiramate exposure in early pregnancy is linked to higher rates of major malformations and more specifically to increased risk of oral clefts, with risk rising at higher doses.
Women's Mental Health published a clinical update in Research Highlights on 26 Mar 2026.
The item focuses on Topiramate and Risk of Major Malformations: What Clinicians and Patients Need to Know.
Review the original article for the full source wording and details.